UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

For The Quarterly Period Ended: December 31, 2011

 

[ ] Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

For The Transition Period From ___________ to _______________

 

 

Commission File Number: 000-29621

 

XSUNX, INC.

(Exact name of registrant as specified in its charter)

 

Colorado		84-1384159
(State of incorporation)		(I.R.S. Employer Identification No.)

 

65 Enterprise, Aliso Viejo, CA 92656

(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number: (949) 330-8060

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, during the preceding twelve (12) months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer ¨

Smaller reporting company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

 

The number of shares of common stock issued and outstanding as of February 13, 2012 was 231,998,637.

 

 

TABLE OF CONTENTS

 

		PAGE
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements		3
Balance Sheets December 31, 2011 (unaudited) and September 30, 2011 (audited)		3
Statements of Operations for the Three Months ended December 31, 2011 and 2010 (unaudited) and the period February 25, 1997 (inception) to December 31, 2011 (unaudited)		4
Statements of Stockholders Equity for the Three Months ended December 31, 2011 (unaudited)		5
Statements of Cash Flows for the Three Months ended December 31, 2011 and 2010 (unaudited) and the period February 27, 1997 (inception) to December 31, 2011 (unaudited)		6
Notes to Financial Statements (unaudited)		7
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		13
Item 3. Qualitative and Quantitative Disclosures About Market Risk		16
Item 4. Controls and Procedures		16
PART II - OTHER INFORMATION
Item 1. Legal Proceedings		17
Item 1A.Risk Factors		17
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		17
Item 3. Defaults upon Senior Securities		17
Item 4. (Removed and Reserved)		17
Item 5. Other Information		17
Item 6. Exhibits		18
Signatures		19

 

 

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

XSUNX, INC.

(A Development Stage Company)

BALANCE SHEETS

		December 31, 2011				September 30, 2011
		(Unaudited)
ASSETS
CURRENT ASSETS
Cash		$	25,467			$	66,576
Prepaid expenses			24,091				9,204
Total Current Assets			49,558				75,780
PROPERTY & EQUIPMENT
Office & miscellaneous equipment			29,841				29,841
Machinery & equipment			177,699				177,699
			207,540				207,540
Less accumulated depreciation			(173,559	)			(164,472	)
Net Property & Equipment			33,981				43,068
OTHER ASSETS
Manufacturing equipment in progress			81,975				81,975
Security deposit			3,200				3,200
Total Other Assets			85,175				85,175
TOTAL ASSETS		$	168,714			$	204,023
LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable		$	194,788			$	167,420
Accrued expenses			11,133				8,740
Credit card payable			1,465				1,099
Accrued interest on notes payable			6,845				95,641
Derivative liability			57,865				—
Convertible promissory notes, net of $79,466 in discounts			16,034				—
Unsecured promissory note			350,000				—
Note payable			—				456,921
Total Current Liabilities			638,130				729,821
TOTAL LIABILITIES			638,130				729,821
SHAREHOLDERS' DEFICIT
Preferred stock, $0.01 par value;
50,000,000 authorized preferred shares			—				—
Common stock, no par value;
500,000,000 authorized common shares
231,998,637 and 209,055,337 shares issued and outstanding, respectively			26,058,369				25,638,369
Additional paid in capital			5,238,213				5,238,213
Paid in capital, common stock warrants			3,719,914				3,635,079
Deficit accumulated during the development stage			(35,485,912	)			(35,037,459	)
TOTAL SHAREHOLDERS' DEFICIT			(469,416	)			(525,798	)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT		$	168,714			$	204,023

 

The accompanying notes are an integral part of these financial statements

XSUNX, INC.

(A Development Stage Company)

STATEMENTS OF OPERATIONS

(Unaudited)

 

										From Inception
										February 25, 1997
		Three Months Ended								through
		December 31, 2011				December 31, 2010				December 31, 2011
REVENUE		$	—			$	—			$	14,880
OPERATING EXPENSES
Selling, general and administrative expenses			204,262				245,433				18,081,061
Research and development			32,278				120,161				3,196,232
Depreciation and amortization expense			9,087				10,619				696,913
TOTAL OPERATING EXPENSES			245,627				376,213				21,974,206
LOSS FROM OPERATIONS BEFORE  OTHER INCOME/(EXPENSE)			(245,627	)			(376,213	)			(21,959,326	)
OTHER INCOME/(EXPENSES)
Interest income			—				—				445,537
Gain/(Loss) on sale of asset			—				—				16,423
Impairment of assets			—				—				(7,285,120	)
Write down of inventory asset			—				—				(1,177,000	)
Gain on legal settlement			—				—				1,279,580
Loan fees			—				—				(7,001,990	)
Forgiveness of debt			—				—				592,154
Loss on conversion of debt			(214,435	)			—				(214,435	)
Amortization of debt discount			(16,034	)			—				(16,034	)
Gain/(Loss) on change in derivative			37,634				—				37,634
Other, non-operating			—				—				(5,215	)
Penalties			(22	)			—				(618	)
Interest expense			(9,969	)			(11,460	)			(197,501	)
TOTAL OTHER INCOME/(EXPENSES)			(202,826	)			(11,460	)			(13,526,585	)
NET LOSS		$	(448,453	)		$	(387,673	)		$	(35,485,911	)
BASIC AND DILUTED LOSS PER SHARE		$	(0.00	)		$	(0.00	)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC AND DILUTED			230,172,550				210,201,552

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements

 

XSUNX, INC.

(A Development Stage Company)

STATEMENT OF SHAREHOLDERS’ DEFICIT

 

 

																		Additional				Stock Options/				Deficit Accumulate during the
		Preferred Stock								Common Stock								Paid-in				Warrants				Development
		Shares				Amount				Shares				Amount				Capital				Paid-in-Capital				Stage				Total
Balance at September 30, 2011			—			$	—				224,998,637			$	25,638,369			$	5,238,213			$	3,635,079			$	(35,037,459	)		$	(525,798	)
Shares issued for conversion of debt at fair value (unaudited)			—				—				7,000,000				420,000				—				—				—				420,000
Stock compensation expense (unaudited)			—				—				—				—				—				84,835				—				84,835
Net loss for the period ended December 31, 2011 (unaudited)			—				—				—				—				—				—				(448,453	)			(448,453	)
Balance at December 31, 2011  (Unaudited)			—			$	—				231,998,637			$	26,058,369			$	5,238,213			$	3,719,914			$	(35,485,912	)		$	(469,416	)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements

XSUNX, INC.

(A Development Stage Company)

STATEMENTS OF CASH FLOWS

(Unaudited)

 

										From Inception
										February 25,1997
		For the Three Months Ended								through
		December 31, 2011				December 31, 2010				December 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss		$	(448,453	)		$	(387,673	)		$	(35,485,911	)
Adjustment to reconcile net loss to net cash
used in operating activities:
Depreciation & amortization			9,087				10,619				696,913
Common stock issued for services and interest			—				—				1,996,634
Stock option and warrant expense			84,835				48,229				3,994,104
Beneficial conversion and commitment fees			—				—				5,685,573
Asset impairment			—				—				7,285,120
Write down of inventory asset			—				—				1,177,000
Gain on settlement of debt			—				—				(466,961	)
(Gain)/Loss on sale of asset			—				—				(16,423	)
Settlement of lease			—				—				59,784
Loss on conversion of debt			214,435				—				214,435
Change in derivative liability			(37,634	)			—				(37,634	)
Amortization of discount on convertible promissory notes			16,034				—				16,034
Change in Assets and Liabilities:
(Increase) Decrease in:
Prepaid expenses			(14,887	)			6,095				(24,091	)
Inventory held for sale			—				—				(1,417,000	)
Other receivable			—				—				—
Other assets			—				—				(3,200	)
Increase (Decrease) in:
Accounts payable			27,732				(23,779	)			2,397,832
Accrued expenses			12,242				19,425				127,352
NET CASH USED IN OPERATING ACTIVITIES			(136,609	)			(327,084	)			(13,800,439	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of manufacturing equipment and facilities in process			—				—				(5,906,604	)
Payments on note receivable			—				—				(1,500,000	)
Proceeds from sale of assets			—				—				261,100
Receipts on note receivable			—				—				1,500,000
Purchase of marketable prototype			—				—				(1,780,396	)
Purchase of fixed assets			—				(899	)			(597,972	)
NET CASH PROVIDED/(USED) BY INVESTING ACTIVITIES			—				(899	)			(8,023,872	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from warrant conversion			—				—				3,306,250
Proceeds from debentures			95,500				—				5,945,500
Proceeds for issuance of common stock, net			—				175,000				12,598,028
NET CASH PROVIDED BY FINANCING ACTIVITIES			95,500				175,000				21,849,778
NET INCREASE (DECREASE) IN CASH			(41,109	)			(152,983	)			25,467
CASH, BEGINNING OF PERIOD			66,576				200,422				—
CASH, END OF PERIOD		$	25,467			$	47,439			$	25,467
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid		$	120			$	37			$	120,131
Taxes paid		$	—			$	—			$	—
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
During the three months ended December 31, 2011, in exchange for the note of $456,920 plus accrued interest of $98,645 that was due at September 1, 2011, the Company issued 7,000,000 restricted shares of common stock as payment for the reduction of $205,565 of principal balance and accrued interest under the note, and issued a new unsecured promissory exchange note in the amount of $350,000

 

The accompanying notes are an integral part of these financial statements

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

December 31, 2011

 

 

1.       BASIS OF PRESENTATION

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended December 31, 2011 are not necessarily indicative of the results that may be expected for the year ending September 30, 2012. For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended September 30, 2011.

 

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has obtained funds from its shareholders since its inception through the period ended December 31, 2011. Management believes the existing shareholders and the prospective new investors will provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core of business.

 

2.       SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies of XsunX, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

 

Development Stage Activities and Operations

The Company has been in its initial stages of formation and for the three months ended December 31, 2011, had no revenues. A development stage activity as one in which all efforts are devoted substantially to establishing a new business and even if planned principal operations have commenced, revenues are insignificant.

 

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, and the fair value of stock options. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

For purposes of the statements of cash flows, cash and cash equivalents include cash in banks and money markets with an original maturity of three months or less.

 

Fair Value of Financial Instruments

The Company’s financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities are carried at cost, which approximates their fair value, due to the relatively short maturity of these instruments. As of December 31, 2011, and September 30, 2011, the Company’s notes payable have stated borrowing rates that are consistent with those currently available to the Company and, accordingly, the Company believes the carrying value of these debt instruments approximates their fair value.

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

December 31, 2011

 

2.       SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Loss per Share Calculations

Loss per Share is the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the three months ended December 31, 2011 as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss.

 

Revenue Recognition

The Company recognizes revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date the Company has had minimal revenue and is still in the development stage.

 

Stock-Based Compensation

Share-based Payment applies to transactions in which an entity exchanges its equity instruments for goods or services and also applies to liabilities an entity may incur for goods or services that are to follow a fair value of those equity instruments. We are required to follow a fair value approach using an option-pricing model, such as the Black Scholes option valuation model, at the date of a stock option grant. The deferred compensation calculated under the fair value method would then be amortized over the respective vesting period of the stock option. This has not had a material impact on our results of operations.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2011, the balances reported for cash, prepaid expenses, accounts payable, accrued expenses, and derivative liability approximate the fair value because of their short maturities.

 

We adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) as of January 1, 2008 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

 

·

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

·

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

·

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2011:

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

December 31, 2011

 

2.       SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Fair Value of Financial Instruments (Continued)

 

		Total				(Level 1)				(Level 2)				(Level 3)
Assets		$	—			$	—			$	—			$	—
Total assets measured at fair value		$	—			$	—			$	—			$	—
Liabilities
Derivative Liability		$	57,865			$	—			$	—			$	57,865
Convertible Debenture, net of discount			16,034				—				—				16,034
Total liabilities measured at fair value		$	73,899			$	—			$	—			$	73,899

 

Recently Adopted Accounting Pronouncements

Management reviewed accounting pronouncements issued during the three month period ended December 31, 2011, and the following pronouncements were adopted:

 

The Company adopted ASC TOPIC 815 "Accounting for Derivative Instruments and Hedging Activities". This pronouncement addresses the accounting for derivative instruments including certain derivative instruments embedded in other contracts, and hedging activities. Derivative instruments that meet the definition of assets and liabilities should be reported in the financial statements at fair value, and any gain or loss should be recognized in current earnings. The adoption of this pronouncement did not have a material effect on the financial statements of the Company.

 

3.

CAPITAL STOCK

 

At December 31, 2011, the Company’s authorized stock consisted of 500,000,000 shares of common stock, with no par value. The Company is also authorized to issue 50,000,000 shares of preferred stock with a par value of $0.01 per share. The rights, preferences and privileges of the holders of the preferred stock will be determined by the Board of Directors prior to issuance of such shares.

 

During the three months ended December 31, 2011, the Company issued 7,000,000 restricted shares of common stock as payment for the reduction of $205,565 of principal and accrued interest balance under a note originally issued by the Company in August 2009. As of the date of the transaction the fair value of the shares issued for the debt reduction was $420,000 resulting in a loss on conversion of $214,435. The above shares were issued in a transactions exempt from registration pursuant to Section 4(2) of the Securities Act.

 

During the three months ended December 31, 2010, pursuant to an S-1 Registration Statement declared effective by the SEC on June 30, 2010, the Company sold to Lincoln Park Capital Group, LLC (LPC) a total of approximately 1,963,940 shares for a total investment of $175,000. These shares were sold at various pricing between $0.08 and $0.09 per share. An additional 48,609 of a remaining pool of 1,250,000 commitment shares were issued on a pro rata basis to LPC as LPC has purchased additional shares pursuant to the effective S-1 Registration Statement.

 

4.

STOCK OPTIONS AND WARRANTS

 

The Company adopted a Stock Option Plan for the purposes of granting stock options to its employees and others providing services to the Company, which reserves and sets aside for the granting of Options for Twenty Million (20,000,000) shares of Common Stock. Options granted under the Plan may be either Incentive Options or Nonqualified Options and shall be administered by the Company's Board of Directors ("Board"). Each Option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective Option agreements may provide. Notwithstanding any other provision of the Plan or of any Option agreement, each Option shall expire on the date specified in the Option agreement.

 

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

December 31, 2011

 

4.

STOCK OPTIONS AND WARRANTS (Continued)

			For the period ended
			12/31/2011
Risk free interest rate			1.14% to 2.77%
Stock volatility factor			90.56% to 104.73%
Weighted average expected option life			5 years
Expected dividend yield			None

A summary of the Company’s stock option activity and related information follows:

		For the period ended
		12/31/2011
						Weighted
		Number				average
		of				exercise
		Options				price
Outstanding, beginning of the period			21,180,000			$	0.18
Granted			—				—
Exercised			—				—
Expired			(230,000	)			0.18
Outstanding, end of the period			20,950,000			$	0.18
Exercisable at the end of the period			8,850,000			$	0.24
Weighted average fair value of
options granted during the period						$	0.46

 

The weighted average remaining contractual life of options outstanding issued under the plan as of December 31, 2011 was as follows:

 

										Weighted
										Average
		Stock				Stock				Remaining
Exercisable		Options				Options				Contractual
Prices		Outstanding				Exercisable				Life (years)
$0.46			1,150,000				1,050,000				0.06 years
$0.53			100,000				100,000				0.15 years
$0.45			100,000				100,000				0.31 years
$0.41			100,000				100,000				0.66 years
$0.36			2,500,000				1,500,000				0.82 years
$0.36			500,000				500,000				0.87 years
$0.36			500,000				500,000				0.91 years
$0.16			5,000,000				5,000,000				2.25 years
$0.10			1,000,000				—				3.80 years
$0.10			10,000,000				—				3.80 years
			20,950,000				8,850,000

 

The 11,000,000 options issued are not part of the Company’s 2007 Option Plan.

 

Stock-based compensation expense recognized during the period is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. Stock-based compensation expense recognized in the financial statements of operations during the three months ended December 31, 2011, included compensation expense for the stock-based payment awards granted prior to, but not yet vested, as of December 31, 2011 based on the grant date fair value estimated, and compensation expense for the stock-based payment awards granted subsequent to December 31, 2011, based on the grant date fair value estimated. We account for forfeitures as they occur. The stock-based compensation expense recognized in the statement of operations during the three months ended December 31, 2011 and 2010 was $84,835 and $48,229, respectively.

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

December 31, 2011

 

4.	STOCK OPTIONS AND WARRANTS (Continued)

 

Warrants

A summary of the Company’s warrants activity and related information follows:

		For the period ended
		12/31/2011
						Weighted
		Number				average
		of				exercise
		Options				price
Outstanding, beginning of the period			4,195,332			$	0.61
Granted			—			$	—
Exercised			—			$	—
Expired			—			$	—
Outstanding, end of the period			4,195,332			$	0.61
Exercisable at the end of period			4,047,332			$	0.64
Weighted average fair value of
warrants granted during the period						$	—

 

At December 31, 2011, the weighted average remaining contractual life of warrants outstanding:

										Weighted
										Average
										Remaining
Exercisable		Warrants				Warrants				Contractual
Prices		Outstanding				Exercisable				Life (years)
$1.69			112,000				112,000				0.26 years
$0.51			500,000				352,000				0.55 years
$0.20			250,000				250,000				1.00 years
$0.50			1,666,666				1,666,666				1.84 years
$0.75			1,666,666				1,666,666				1.84 years
			4,195,332				4,047,332

5.     PROMISSORY NOTE

 

During the year ended September 30, 2009, the Company converted an account payable to a promissory note (the “Note”) in the amount of $456,920. On November 3, 2011, in exchange for the Note of $456,920 plus accrued interest of $98,645 that had become due at September 1, 2011, the Company issued 7,000,000 restricted shares of common stock with a fair value of $420,000 as payment for the reduction of $205,565 of principal balance and accrued interest under the Note, and incurred a loss on the conversion of the debt in the amount of $214,435. Also, as part of the payment of the note, the Company issued a new unsecured promissory exchange note (the “Exchange Note”) in the amount of $350,000. The note bears interest at 10% per annum and matures on September 30, 2012.

 

6.     CONVERTIBLE PROMISSORY NOTES

 

On October 27, 2011, and December 7, 2011 the Company entered into two Securities Purchase Agreements (the "Purchase Agreements") providing for the sale by the Company of 8% unsecured Convertible Notes (“the Notes”) in the aggregate principal amounts of $53,000 and $42,500, respectively. The October 27, 2011 Note in the amount of $53,000 matures on July 31, 2012, and the December 7, 2011 Note in the amount of $42,500 matures on September 12, 2012. The Company has the right to redeem a portion or all amounts outstanding under the either Note prior to one hundred and eighty one days from issuance of the Note under a variable redemption rate premium. After one hundred and eighty days the holder may convert into shares of common stock at a variable conversion price of 60% multiplied by the market

 

XSUNX, INC.

(A Development Stage Company)

Notes to Financial Statements – (Unaudited)

December 31, 2011

 

6.     CONVERTIBLE PROMISSORY NOTES (Continued)

 

price of the average lowest five (5) trading prices for the common stock during the ten (10) trading days prior to the conversion date.

 

ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability of $63,670 representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount of $95,500 representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, which resulted in the recognition of $16,034 in interest expense for the period ended December 31, 2011, and the derivative liability is adjusted periodically according to stock price fluctuations. At the time of conversion, any remaining derivative liability will be charged to additional paid-in capital. For purpose of determining the fair market value of the derivative liability, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows:

 

Stock price on the valuation dates		$	0.02
Conversion price for the debt		$	0.0144
Dividend yield			0.00	%
Months to Maturity			9
Risk free rate			0.12	%
Expected volatility			85.15	%

 

The value of the derivative liability at December 31, 2011 was $57,865.

 

7.     SUBSEQUENT EVENTS

 

The following are items management has evaluated as subsequent events pursuant to the requirement of ASC Topic 855.

 

On January 17, 2012, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") providing for the sale by the Company of 8% unsecured Convertible Notes in the aggregate principal amount of $32,500 (the “Note”) which amount was advanced immediately at the time of sale. The Note matures on October 19, 2012. The Company has the right to redeem a portion or all amounts outstanding under the either Note prior to one hundred and eighty one days from issuance of the Note under a variable redemption rate premium. After one hundred and eighty days the holder may convert into shares of common stock at a conversion price of sixty percent of the average lowest five closing bid prices for the common stock, during the ten trading day period ending on the latest complete trading day prior to the conversion date. The holder has certain rights of first refusal related to financings of less than seventy five thousand dollars by the Company, and in the event of certain default conditions the Company may be subject a default premium of fifty percent.

 

On January 11, 2012, the Company granted 500,000 stock options to each of the three non-affiliated members of the Board of Directors for a total of 1,500,000 options for continued services to the Company. Each option provides for a purchase price of $0.045 per share (112% of the market price on the date of grant) and can be exercised over a five year period.

 

 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

CAUTIONARY AND FORWARD LOOKING STATEMENTS

 

In addition to statements of historical fact, this Quarterly Report on Form 10-Q contains forward-looking statements. The presentation of future aspects of XsunX, Inc. ("XsunX", the "Company" or "issuer") found in these statements is subject to a number of risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. Without limiting the generality of the foregoing, words such as "may", "will", "expect", "believe", "anticipate", "intend", or "could" or the negative variations thereof or comparable terminology are intended to identify forward-looking statements. Our actual results could differ materially from those anticipated by these forward-looking statements as a result of many factors, including those discussed under “Item 1A: Risk Factors” in the Company’s Annual Report on Form 10-K and elsewhere in this Quarterly Report on Form 10-Q.

 

These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause XsunX's actual results to be materially different from any future results expressed or implied by XsunX in those statements. Important facts that could prevent XsunX from achieving any stated goals include, but are not limited to, the following:

 

Some of these risks might include, but are not limited to, the following:

 

(a)

volatility or decline of the Company's stock price;

 

(b)

potential fluctuation in quarterly results;

 

(c)

failure of the Company to earn revenues or profits;

 

(d)

inadequate capital to continue or expand its business, inability to raise additional capital or financing to implement its business plans;

 

(e)

failure to commercialize its technology or to make sales;

 

(f)

rapid and significant changes in markets;

 

(g)

litigation with or legal claims and allegations by outside parties;

 

(h)

insufficient revenues to cover operating costs.

 

There is no assurance that the Company will be profitable, the Company may not be able to successfully develop, manage or market its products and services, the Company may not be able to attract or retain qualified executives and technology personnel, the Company's products and services may become obsolete, government regulation may hinder the Company's business, additional dilution in outstanding stock ownership may be incurred due to the issuance of more shares, warrants and stock options, or the exercise of warrants and stock options, and other risks inherent in the Company's businesses.

 

The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K filed by the Company and any Current Reports on Form 8-K filed by the Company.

 

Management believes the summary data presented herein is a fair presentation of the Company's results of operations for the periods presented. Due to the Company's change in primary business focus and new business opportunities these historical results may not necessarily be indicative of results to be expected for any future period. As such, future results of the Company may differ significantly from previous periods.

 

Business Overview

 

XsunX, Inc. is developing and has begun to market a hybrid manufacturing solution to produce high performance Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Our patent pending processing technology, which we call CIGSolar™, focuses on the mass production of individual thin-film CIGS solar cells that match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. We intend to

 

offer licenses for the use of the CIGSolar™ process technology thereby generating revenue streams through licensing fees and manufacturing royalties for the use of the technology.

 

Our efforts have been focused on the development and customization of a series of specialized processing tools that when combined provide a turn-key high-throughput manufacturing system to produce CIGS solar cells.

 

Core attributes to our process method are the use of small area thermal co-evaporation techniques coupled with state-of-the-art sputter deposition technologies to improve manufacturing output, increase cell efficiency, production yields, and lower the costs for the production of high efficiency CIGS cells.

 

There are five (5) core process tools that when combined will produce 156mm format (about 6” square) solar cells. We believe that it will be the ability of our system to minimize processing defects while maintaining exceptional per hour production rates that will provide superior commercial opportunities. CIGSolar™ cells will be manufactured on stainless steel squares sized to match silicon solar cells currently used in nearly 75% of all solar modules manufactured today.

 

This innovative approach bridges the gap between inexpensive thin-film and costly high efficiency silicon wafer technologies to produce a new breed of solar cell combining what we believe are the best attributes of each technology. The mass production of individual, high performance CIGS solar cells – like solar building blocks – we believe will allow solar power to finally compete effectively against other sources of electrical energy.

 

RESULTS OF OPERATIONS FOR THE THREE-MONTH PERIOD ENDED DECEMBER 31, 2011 COMPARED TO THE SAME PERIOD IN 2010

 

Revenue:

 

The Company generated no revenues for the periods ended December 31, 2011 and 2010 respectively. Additionally, there was no associated cost of sales. The Company to date has had minimal revenue and cost of sales, and is still in the development stage.

 

Selling, General and Administrative Expenses:

 

Selling, general and administrative expenses for the three month period ending December 31, 2011 were $204,262 as compared to $245,433 during the same period in 2010. The decrease of $(41,171) was related primarily to a general reduction to salaries, staffing, and operating expenses under the Company’s re-focused plan of operations for the development of a new CIGSolar™ thin film solar manufacturing technology. We anticipate that expenditures associated with the commercial development and sales of our thin-film solar manufacturing technologies will increase SG&A expenditures in the future. However, we plan to offer our technology as a licensable process to existing solar product manufacturers which we anticipate will mitigate future expenditures that would normally be associated with our need to establish direct large scale manufacturing capabilities and the associated facility infrastructure.

 

Research and Development:

 

Research and development for the three month period ended December 31, 2011 were $32,278 as compared to $120,161 during the same period in 2010. The decrease of $(87,883) was primarily due to a reduction in research related efforts used in the period on the development of our new cross-industry thin film solar manufacturing technology CIGSolar™. During the period we continued to focus efforts to build a full sized multi-chamber CIGSolar™ processing system for use in continued process improvement, marketing efforts, and future systems sales support. We anticipate that future R&D expense will again increase as we complete this process.

 

Net Loss:

 

The net loss for the three months ended December 31, 2011 was $(448,453) as compared to a net loss of $(387,673) for the same period 2010. The increase in net loss of $(60,780) primarily includes the reduction to operating expenses of $129,054 and an increase to the Company’s non-cash expenses during the period, which consisted of a loss on conversion of debt for $(214,435), amortization of debt discount of $(16,034), the gain on change in derivative of $37,634, and the net change of depreciation for $1,532. The Company anticipates the trend of losses to continue in future periods until the Company can recognize sales of significance of which there is no assurance.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of December 31, 2011, we had a working capital deficit of $(588,572) as compared to $(654,041) at September 30,

 

2011. This decrease in working capital deficit of $(65,469) was due primarily to a decrease in equity financing.

 

During the three months ended December 31, 2011, the Company used $(133,421) of cash for operating activities, as compared to cash used of $(327,084) for the same period 2010. The decrease in cash used of $(193,663) for operating activities was primarily due to an increase in prepaid expenses, accounts payable, and to a general reduction to salaries, staffing, and operating expenses under the Company’s re-focused plan of operations for the development of a new CIGSolar™ thin film solar manufacturing technology.

 

Cash provided by investing activities for the three months ended December 31, 2011 was $0, as compared to cash used of $(899) for the same period 2010. The net decrease of cash used in investing activities was primarily due to a decrease in the purchase of small fixed assets

 

Cash provided by financing activities for the three months ended December 31, 2011 was $95,500, as compared to $175,000 for the same period 2010. Our capital needs have primarily been met from the proceeds of private placements, as we are currently in the development stage and had no revenues.

 

Our financial statements as of December 31, 2011 have been prepared under the assumption that we will continue as a going concern from inception (February 25, 1997) through December 31, 2011. Our independent registered public accounting firm has issued their report dated December 29, 2011, that included an explanatory paragraph expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. Our ability to continue as a going concern ultimately is dependent on our ability to generate a profit which is dependent upon our ability to obtain additional equity or debt financing, attain further operating efficiencies and, ultimately, to achieve profitable operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

For the three months ended December 31, 2011, the Company's capital needs have been met from the use of working capital provided by the proceeds of (i) the Company’s working capital and (ii) the sale of convertible debt proceeds totaling $95,500.

 

Lincoln Park Capital Fund, LLC Transaction

 

On March 30, 2010, XsunX signed a $5 million stock purchase agreement with Lincoln Park Capital Fund, LLC (“LPC”), an Illinois limited liability company. Upon signing the agreement, XsunX received $500,000 from LPC as an initial purchase under the $5 million dollar commitment in exchange for 5,000,000 shares of our common stock. We also entered into a registration rights agreement with LPC whereby we agreed to file a registration statement related to the transaction with the U.S. Securities & Exchange Commission (“SEC”) covering the shares that have been issued or may be issued to LPC under the purchase agreement. On April 30, 2010, XsunX, Inc. filed a Form S-1 with the Securities and Exchange Commission seeking to register 27,500,000 shares related to our financing agreements with LPC. The registration was declared effective by the Securities and Exchange Commission on June 30, 2010. On March 29, 2011 we filed a Post-Effective Amendment No. 1 Form S-1 with the Securities and Exchange Commission seeking to maintain the registration for the 27,500,000 shares related to our financing agreements with LPC. The Post-Effective Amendment No. 1 registration was declared effective by the Securities and Exchange Commission on April 4, 2011. Subject to the effective registration statement related to the transaction, we have the right over a 25-month period to sell our shares of common stock to LPC in amounts up to $500,000 per sale, depending on certain conditions as set forth in the purchase agreement, up to the aggregate commitment of $5 million.

 

There are no upper limits to the price LPC may pay to purchase our common stock, and the purchase price of the shares related to the $4.5 million of future funding will be based on the prevailing market prices of the Company’s shares at the time of sales without any fixed discount. The Company will control the timing and amount of any sales of shares to LPC. LPC shall not have the right or the obligation to purchase any shares of our common stock on any business day that the price of our common stock is below $0.08.

 

In consideration for entering into the $5 million agreement which provides for an additional $4.5 million of future funding, we issued to LPC 1,250,000 shares of our common stock as a financing inception commitment and shall issue an equivalent amount of shares pro rata as LPC purchases the additional $4.5 million. The common stock purchase agreement may be terminated by us at any time at our discretion without any cost to us. Except for a limitation on variable priced financings, there are no negative covenants, restrictions on future funding’s, penalties or liquidated damages in the agreement. The proceeds received by the Company under the common stock purchase agreement are expected to be used in the development of thin film manufacturing equipment and technologies, general and administrative costs, and general working capital.

 

 

Pursuant to the stock purchase agreement with LPC and the S-1 Registration Statement declared effective by the SEC on June 30, 2010, the Company has sold to Lincoln Park Capital Fund, LLC through December 31, 2011, approximately 12,410,184 shares for a total investment of $1,125,000 including the initial $500,000 and 5,000,000 shares. These shares were sold at various pricing between $0.08 and $0.10 per share. Including 1,250,000 shares provided to LPC as financing inception commitment shares, and an additional 173,608 commitment shares issued pro rata as LPC has purchased additional shares, as of December 31, 2011 13,666,208 registered shares remain available for future sales pursuant to the effective S-1 Registration Statement. The registration statement is currently not available for use for sales to Lincoln Park.

 

DEVELOPMENT STAGE COMPANY

 

The Company is currently engaged in efforts to develop a cross-industry thin film solar manufacturing concept that we believe provides an opportunity for XsunX to establish a competitive advantage within the solar industry, and as of the period ended December 31, 2011, did not have any significant revenues. The transition to revenue recognition may exceed cash generated from operations in the current and future periods. We have in the past experienced substantial losses and negative cash flow from operations and have required financing, including equity and debt financing, in order to pursue the commercialization of products based on our technologies. We expect that we will continue to need significant financing to operate our business. If additional financing is not available or not available on terms acceptable to us, our ability to fund our operations, maintain our research and development efforts necessary to complete the development of marketable products or otherwise respond to competitive pressures may be significantly impaired. We could also be forced to curtail our business operations, reduce our investments, decrease or eliminate capital expenditures and delay the execution of our business plan which would have a material adverse affect on our business.

 

While we have been able to raise capital in a series of equity and debt offerings in the past there can be no assurances that we will be able to obtain such additional financing, on terms acceptable to us and at the times required, or at all.

 

Irrespective of whether the Company's cash assets prove to be inadequate to meet the Company's operational needs, the Company might seek to compensate providers of services by issuances of stock in lieu of cash.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, results of operations, liquidity or capital expenditures.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We do not have any market risk sensitive instruments. Since all operations are in U.S. dollar denominated accounts, we do not have foreign currency risk. Our operating costs are reported in U.S. dollars.

 

The Company does not invest in term financial products or instruments or derivatives involving risk other than money market accounts, which fluctuate with interest rates at market.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer, principal financial officer, and principal operating officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

As required by SEC Rule 15d-15(e), our management carried out an evaluation, under the supervision and with the participation of our principal executive officer, principal financial officer, and principal operating officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our principal executive officer, principal financial officer, and principal accounting officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

 

 

Changes in Internal Control over Financial Reporting

 

There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended December 31, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

In the ordinary conduct of our business, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

 

Item 1A. Risk Factors

 

There are no material changes from the risk factors previously disclosed in the Registrant’s Form 10-K filed on December 29, 2011.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On November 3, 2011, in exchange for promissory note (the “Note”) of $456,920 plus accrued interest of $98,645 that had become due at September 1, 2011, the Company issued 7,000,000 restricted shares of common stock as payment for the reduction of $205,565 of principal and accrued interest balance under the Note, and exchanged the Note for and issued a new unsecured promissory exchange note (the “Exchange Note”) in the amount of $350,000.

 

On October 27, 2011, and again on December 7, 2011 the Company entered into Securities Purchase Agreements (the "Purchase Agreements") providing for the sale by the Company of 8% unsecured Convertible Notes in the aggregate principal amount of $53,000 and $42,500 respectively (the “Note”) which amounts were advanced immediately at the time of each sale. After one hundred and eighty days the holder may convert into shares of common stock at a conversion price of sixty percent of the average lowest five closing bid prices for the common stock, during the ten trading day period ending on the latest complete trading day prior to the conversion date.

 

Use of Proceeds from the Sale of Securities

 

The proceeds from the above sales of securities were and are being used primarily to fund efforts by the Company to develop marketable technologies for the manufacture of thin film solar technologies, and in the day-to-day operations of the Company and to pay the accrued liabilities associated with these operations.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. (Removed and Reserved)

 

Item 5. Other information

 

On January 17, 2012, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") providing for the sale by the Company of 8% unsecured Convertible Notes in the aggregate principal amount of $32,500 (the “Note”) which amount was advanced immediately at the time of sale. The Note matures on October 19, 2012. The Company has the right to redeem a portion or all amounts outstanding under the either Note prior to one hundred and eighty one days from issuance of the Note under a variable redemption rate premium. After one hundred and eighty days the holder may convert into shares of common stock at a conversion price of sixty percent of the average lowest five closing bid prices for the common stock, during the ten trading day period ending on the latest complete trading day prior to the conversion date. The holder has certain rights of first refusal related to financings of less than seventy five thousand dollars by the Company, and in the event of certain default conditions the Company may be subject a default premium of fifty percent.

 

 

As part of the Company’s operating plans, and efforts to maximize the use of its capital resources towards the assembly of its initial baseline multi-chamber CIGSolar™ thermal co-evaporation system, the Company’s CEO, COO, and CTO agreed effective October 2011 to salary reductions under which each executive would receive an annualized salary of $120,000.

 

On January 11, 2012, the Company granted 500,000 stock options to each of the three non-affiliated members of the Board of Directors for a total of 1,500,000 options for continued services to the Company. Each option provides for a purchase price of $0.045 per share (112% of the market price on the date of grant) and can be exercised over a five year period.

 

Item 6. Exhibits

 

3.1		Articles of Incorporation(1)
3.2		Bylaws(2)
10.1		XsunX Plan of Reorganization and Asset Purchase Agreement, dated September 23, 2003.(3)
10.2		XsunX 2007 Stock Option Plan, dated January 5, 2007.(4)
10.3		Common Stock Purchase Agreement dated as of March 30, 2010, by and between the Company and Lincoln Park Capital Fund, LLC. (5)
10.4		Registration Rights Agreement dated as of March 30, 2010, by and between the Company and Lincoln Park Capital Fund, LLC. (5)
10.5		Form S-1 and S-1/A related to the filing of a registration statement by the Company (6)(7)
10.6		Form S-1/A related to the filing of a Post-Effective Amendment No. 1 registration statement by the Company. (8)
10.9		Form of Exchange Agreement and Exchange Note used in connection with the exchange, partial repayment, and extension to a promissory note that had become due September 1, 2011. (9)
10.10		Form of Securities Purchase Agreement and Convertible Promissory Note used in connection with the sale of two convertible promissory notes in the aggregate amount of $95,500. (9)
10.11		Form of Securities Purchase Agreement and Convertible Promissory Note used in connection with the sale of a convertible promissory note in the aggregate amount of $32,500. (9)
10.12		Form of Stock Option Agreement used by the Company to grant 500,000 common stock purchase options to each of three unaffiliated members of the Board of Directors on January 11, 2012. (10)
31.1		Sarbanes-Oxley Certification (10)
32.1		Sarbanes-Oxley Certification (10)
(1)		Incorporated by reference to Registration Statement Form 10SB12G #000-29621dated February 18, 2000 and by reference to exhibits included with the Company’s prior Report on Form 8-K/A filed with the Securities and Exchange Commission dated October 29, 2003.
(2)		Incorporated by reference to Registration Statement Form 10SB12G #000-29621 filed with the Securities and Exchange Commission dated February 18, 2000.
(3)		Incorporated by reference to exhibits included with the Company’s Report on Form 8-K/A filed with the Securities and Exchange Commission dated October 29, 2003.
(4)		Incorporated by reference to exhibits included with the Company’s Report on Form 8-K filed with the Securities and Exchange Commission dated January 5, 2007.
(5)		Incorporated by reference to exhibits included with the Company’s Report on Form 8-K filed with the Securities and Exchange Commission dated April 1, 2010.
(6)		Incorporated by reference to exhibits included with the Company’s Report on Form S-1 filed with the Securities and Exchange Commission dated April 30, 2010.
(7)		Incorporated by reference to exhibits included with the Company’s Report on Form S-1/A filed with the Securities and Exchange Commission dated June 25, 2010.
(8)		Incorporated by reference to exhibits included with the Company’s Post-Effective Amendment No.1 Report on Form S-1/A filed with the Securities and Exchange Commission dated March 29, 2011.
(9)		Incorporated by reference to exhibits included with the Company’s Report on Form 10-K filed with the Securities and Exchange Commission dated December 29, 2011.
(10)		Provided herewith Incorporated by reference to exhibits included with the Company’s Report on Form 10-Q filed with the Securities and Exchange Commission dated February 13, 2012.

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	XSUNX, INC.
Dated: February 13, 2012	By:	/s/ Tom M. Djokovich
		Tom M. Djokovich, Principal Executive and Financial Officer